CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Corporation announced today that Dr. Christopher Pritchard will assume the role of Chief Science Officer, effective immediately. Dr. Pritchard has served several important research and development roles since he began his work with InVivo co-founder Frank Reynolds in 2007. His most recent position at InVivo was Director of Research & Development.
